Tabchi, S <br/><br/>
Regorafenib: start low and go slow.  [electronic resource] 

 -  Targeted oncology  Sep 2015 
 - 445-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1776-260X 
<br/><br/><label>Standard No.: </label>10.1007/s11523-014-0352-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Clinical Trials, Phase III as Topic<br/>Colorectal Neoplasms--drug therapy<br/>Disease Progression<br/>Drug Administration Schedule<br/>Gastrointestinal Tract--drug effects<br/>Humans<br/>Neoplasm Metastasis<br/>Phenylurea Compounds--administration & dosage<br/>Pyridines--administration & dosage<br/>Quality of Life<br/>Randomized Controlled Trials as Topic